Literature DB >> 20554828

Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

Li Xiao1, John I Glass, Vanya Paralanov, Shibu Yooseph, Gail H Cassell, Lynn B Duffy, Ken B Waites.   

Abstract

We designed primers and probes for the detection and discrimination of Ureaplasma parvum and U. urealyticum and their 14 serovars by real-time PCR. The analytical sensitivity and specificity of the multiplex species-specific PCR were determined by testing corresponding American Type Culture Collection (ATCC) type strains, 47 other microbial species, and human genomic DNA. The limits of the multiplex PCR were 2.8 x 10(-2) CFU/microl PCR mixture for detecting U. parvum and 4.1 x 10(-2) CFU/microl PCR mixture for detecting U. urealyticum. Clinical specificity and sensitivity were proven by comparison with culture and traditional PCR. For the detection of any Ureaplasma species, the clinical sensitivity and specificity of real-time PCR were 96.9% and 79.0%, respectively, using culture as a reference. Multiplex real-time PCR was also more sensitive than traditional PCR in discriminating the two Ureaplasma species in culture-positive subcultures. Each of the 14 monoplex serovar-specific PCR assays was specific for the corresponding ATCC type strain serovar. This new species identification PCR is specific and sensitive in the detection of Ureaplasma species in clinical specimens, and the serovar-specific PCR assays are the first set of complete genotypic assays to differentiate all 14 known Ureaplasma serovars. These assays provide quick and reliable means for investigating the epidemiology and pathogenicity of ureaplasmas at the serovar level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554828      PMCID: PMC2916572          DOI: 10.1128/JCM.01877-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Differentiation of two biovars of Ureaplasma urealyticum based on the 16S-23S rRNA intergenic spacer region.

Authors:  R Harasawa; Y Kanamoto
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCR-single-strand conformation polymorphism analysis.

Authors:  D Pitcher; M Sillis; J A Robertson
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Direct and indirect immunofluorescence of unfixed and fixed Mycoplasma colonies.

Authors:  S Rosendal; F T Black
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

4.  Modifications of the growth inhibition test and its application to human T-mycoplasmas.

Authors:  F T Black
Journal:  Appl Microbiol       Date:  1973-04

5.  Development of monoclonal antibodies against Ureaplasma urealyticum serotypes and their use for serotyping clinical isolates.

Authors:  F Echahidi; G Muyldermans; S Lauwers; A Naessens
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

6.  Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001.

Authors:  Janet A Robertson; Gerald W Stemke; John W Davis; Ryĵ Harasawa; David Thirkell; Fanrong Kong; Maurice C Shepard; Denys K Ford
Journal:  Int J Syst Evol Microbiol       Date:  2002-03       Impact factor: 2.747

7.  Molecular genotyping of human Ureaplasma species based on multiple-banded antigen (MBA) gene sequences.

Authors:  F Kong; Z Ma; G James; S Gordon; G L Gilbert
Journal:  Int J Syst Evol Microbiol       Date:  2000-09       Impact factor: 2.747

8.  Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis.

Authors:  Takashi Deguchi; Takashi Yoshida; Takamaro Miyazawa; Mitsuru Yasuda; Masayoshi Tamaki; Hiroaki Ishiko; Shin-Ichi Maeda
Journal:  Sex Transm Dis       Date:  2004-03       Impact factor: 2.830

9.  Alternate phase variation in expression of two major surface membrane proteins (MBA and UU376) of Ureaplasma parvum serovar 3.

Authors:  Carl-Ulrich R Zimmerman; Thomas Stiedl; Renate Rosengarten; Joachim Spergser
Journal:  FEMS Microbiol Lett       Date:  2009-02-07       Impact factor: 2.742

10.  The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor.

Authors:  Bo Hyun Yoon; Roberto Romero; June-Hee Lim; Soon-Sup Shim; Joon-Seok Hong; Jae-Yoon Shim; Jong Kwan Jun
Journal:  Am J Obstet Gynecol       Date:  2003-10       Impact factor: 8.661

View more
  34 in total

1.  Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasia.

Authors:  Hazem E Hassan; Ahmed A Othman; Natalie D Eddington; Lynn Duffy; Li Xiao; Ken B Waites; David A Kaufman; Karen D Fairchild; Michael L Terrin; Rose M Viscardi
Journal:  J Clin Pharmacol       Date:  2010-11-23       Impact factor: 3.126

2.  Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Tae-Jung Sung; Li Xiao; Lynn Duffy; Ken B Waites; Kirsty L Chesko; Rose M Viscardi
Journal:  Pediatr Infect Dis J       Date:  2011-05       Impact factor: 2.129

3.  Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Authors:  Rose M Viscardi; Ahmed A Othman; Hazem E Hassan; Natalie D Eddington; Elias Abebe; Michael L Terrin; David A Kaufman; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

4.  Canada: First report of Ureaplasma diversum, a bovine pathogen, in the respiratory tract of swine in Canada.

Authors:  Yaima Burgher; Marika Koszegi; Valérie Grenier St-Sauveur; Dominique Fournier; Cynthia Lafond-Lambert; Chantale Provost; Carl A Gagnon
Journal:  Can Vet J       Date:  2018-12       Impact factor: 1.008

5.  Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.

Authors:  Li Xiao; Donna M Crabb; Lynn B Duffy; Vanya Paralanov; John I Glass; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

Review 6.  Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.

Authors:  Ken B Waites; Li Xiao; Vanya Paralanov; Rose M Viscardi; John I Glass
Journal:  J Mol Diagn       Date:  2012-07-20       Impact factor: 5.568

Review 7.  The Human Ureaplasma Species as Causative Agents of Chorioamnionitis.

Authors:  Emma L Sweeney; Samantha J Dando; Suhas G Kallapur; Christine L Knox
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

8.  Toll-like receptor variants and cervical Atopobium vaginae infection in women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Patricia A Totten; Sabina G Astete; Michael J Ferris; David H Martin; Roberta B Ness; Catherine L Haggerty
Journal:  Am J Reprod Immunol       Date:  2017-12-29       Impact factor: 3.886

9.  Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.

Authors:  L Marcela Merchan; Hazem E Hassan; Michael L Terrin; Ken B Waites; David A Kaufman; Namasivayam Ambalavanan; Pamela Donohue; Susan J Dulkerian; Robert Schelonka; Laurence S Magder; Sagar Shukla; Natalie D Eddington; Rose M Viscardi
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 10.  Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update.

Authors:  Rose Marie Viscardi; Suhas G Kallapur
Journal:  Clin Perinatol       Date:  2015-10-09       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.